Apatinib as second-line therapy in Chinese patients with advanced hepatocellular carcinoma: A randomized, placebo-controlled, double-blind, phase III study.Qiu Li, Chunlei Jin, Xi Chen et al.|Journal of Clinical Oncology|2020Cited by 36
A Randomized, Double‐blind, Placebo‐controlled Trial to Evaluate the Efficacy and Safety of Pregabalin for Postherpetic Neuralgia in a Population of Chinese PatientsQuanzhong Liu, Dongsheng Fan, Haibo Chen et al.|Pain Practice|2015Cited by 31
Neoadjuvant chemoradiation (CRT) with or without panitumumab (Pan) in patients with K-ras-unmutated, locally advanced rectal cancer (LARC): A randomized multicenter phase II trial (SAKK 41/07).Daniel Helbling, Dieter Koeberle, G. Bodoky et al.|Journal of Clinical Oncology|2011Cited by 4